nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—Erlotinib—pancreatic cancer	0.213	0.361	CbGbCtD
Gatifloxacin—ALB—Irinotecan—pancreatic cancer	0.192	0.326	CbGbCtD
Gatifloxacin—ALB—Fluorouracil—pancreatic cancer	0.185	0.313	CbGbCtD
Gatifloxacin—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000336	0.00082	CcSEcCtD
Gatifloxacin—Face oedema—Doxorubicin—pancreatic cancer	0.000335	0.000819	CcSEcCtD
Gatifloxacin—Erythema—Docetaxel—pancreatic cancer	0.000335	0.000818	CcSEcCtD
Gatifloxacin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000335	0.000818	CcSEcCtD
Gatifloxacin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000334	0.000815	CcSEcCtD
Gatifloxacin—Nausea—Tamoxifen—pancreatic cancer	0.000333	0.000813	CcSEcCtD
Gatifloxacin—Gastritis—Epirubicin—pancreatic cancer	0.000332	0.000811	CcSEcCtD
Gatifloxacin—Muscular weakness—Epirubicin—pancreatic cancer	0.000331	0.000808	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000331	0.000808	CcSEcCtD
Gatifloxacin—Constipation—Gemcitabine—pancreatic cancer	0.00033	0.000805	CcSEcCtD
Gatifloxacin—Nausea—Erlotinib—pancreatic cancer	0.00033	0.000805	CcSEcCtD
Gatifloxacin—Decreased appetite—Fluorouracil—pancreatic cancer	0.00033	0.000804	CcSEcCtD
Gatifloxacin—Diarrhoea—Sunitinib—pancreatic cancer	0.000329	0.000803	CcSEcCtD
Gatifloxacin—Dysgeusia—Docetaxel—pancreatic cancer	0.000328	0.000801	CcSEcCtD
Gatifloxacin—Ataxia—Doxorubicin—pancreatic cancer	0.000327	0.000797	CcSEcCtD
Gatifloxacin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000326	0.000796	CcSEcCtD
Gatifloxacin—Asthma—Epirubicin—pancreatic cancer	0.000325	0.000792	CcSEcCtD
Gatifloxacin—Dysphagia—Epirubicin—pancreatic cancer	0.000325	0.000792	CcSEcCtD
Gatifloxacin—Back pain—Docetaxel—pancreatic cancer	0.000324	0.000792	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000324	0.00079	CcSEcCtD
Gatifloxacin—Muscle spasms—Docetaxel—pancreatic cancer	0.000322	0.000787	CcSEcCtD
Gatifloxacin—Dry skin—Doxorubicin—pancreatic cancer	0.000318	0.000777	CcSEcCtD
Gatifloxacin—Pancreatitis—Epirubicin—pancreatic cancer	0.000318	0.000777	CcSEcCtD
Gatifloxacin—Dizziness—Sunitinib—pancreatic cancer	0.000318	0.000776	CcSEcCtD
Gatifloxacin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000318	0.000776	CcSEcCtD
Gatifloxacin—Body temperature increased—Irinotecan—pancreatic cancer	0.000313	0.000764	CcSEcCtD
Gatifloxacin—Abdominal pain—Irinotecan—pancreatic cancer	0.000313	0.000764	CcSEcCtD
Gatifloxacin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000312	0.000763	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000311	0.000758	CcSEcCtD
Gatifloxacin—Gastritis—Doxorubicin—pancreatic cancer	0.000307	0.000751	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000306	0.000748	CcSEcCtD
Gatifloxacin—Muscular weakness—Doxorubicin—pancreatic cancer	0.000306	0.000748	CcSEcCtD
Gatifloxacin—Vomiting—Sunitinib—pancreatic cancer	0.000305	0.000746	CcSEcCtD
Gatifloxacin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000305	0.000744	CcSEcCtD
Gatifloxacin—Dysuria—Epirubicin—pancreatic cancer	0.000303	0.000741	CcSEcCtD
Gatifloxacin—Neutropenia—Epirubicin—pancreatic cancer	0.000303	0.000741	CcSEcCtD
Gatifloxacin—Rash—Sunitinib—pancreatic cancer	0.000303	0.00074	CcSEcCtD
Gatifloxacin—Dermatitis—Sunitinib—pancreatic cancer	0.000303	0.000739	CcSEcCtD
Gatifloxacin—Urticaria—Fluorouracil—pancreatic cancer	0.000301	0.000735	CcSEcCtD
Gatifloxacin—Headache—Sunitinib—pancreatic cancer	0.000301	0.000735	CcSEcCtD
Gatifloxacin—Syncope—Docetaxel—pancreatic cancer	0.000301	0.000734	CcSEcCtD
Gatifloxacin—Dysphagia—Doxorubicin—pancreatic cancer	0.0003	0.000733	CcSEcCtD
Gatifloxacin—Asthma—Doxorubicin—pancreatic cancer	0.0003	0.000733	CcSEcCtD
Gatifloxacin—Body temperature increased—Fluorouracil—pancreatic cancer	0.0003	0.000732	CcSEcCtD
Gatifloxacin—Palpitations—Docetaxel—pancreatic cancer	0.000296	0.000723	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000296	0.000723	CcSEcCtD
Gatifloxacin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000295	0.000719	CcSEcCtD
Gatifloxacin—Pancreatitis—Doxorubicin—pancreatic cancer	0.000294	0.000719	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000293	0.000715	CcSEcCtD
Gatifloxacin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000292	0.000712	CcSEcCtD
Gatifloxacin—Convulsion—Docetaxel—pancreatic cancer	0.00029	0.000709	CcSEcCtD
Gatifloxacin—Hypertension—Docetaxel—pancreatic cancer	0.000289	0.000707	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000287	0.0007	CcSEcCtD
Gatifloxacin—Myalgia—Docetaxel—pancreatic cancer	0.000285	0.000697	CcSEcCtD
Gatifloxacin—Arthralgia—Docetaxel—pancreatic cancer	0.000285	0.000697	CcSEcCtD
Gatifloxacin—Chest pain—Docetaxel—pancreatic cancer	0.000285	0.000697	CcSEcCtD
Gatifloxacin—Nausea—Sunitinib—pancreatic cancer	0.000285	0.000697	CcSEcCtD
Gatifloxacin—Asthenia—Irinotecan—pancreatic cancer	0.000284	0.000693	CcSEcCtD
Gatifloxacin—Stomatitis—Epirubicin—pancreatic cancer	0.000282	0.000689	CcSEcCtD
Gatifloxacin—Conjunctivitis—Epirubicin—pancreatic cancer	0.000281	0.000687	CcSEcCtD
Gatifloxacin—Dysuria—Doxorubicin—pancreatic cancer	0.000281	0.000685	CcSEcCtD
Gatifloxacin—Neutropenia—Doxorubicin—pancreatic cancer	0.000281	0.000685	CcSEcCtD
Gatifloxacin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000279	0.000682	CcSEcCtD
Gatifloxacin—Sweating—Epirubicin—pancreatic cancer	0.000277	0.000677	CcSEcCtD
Gatifloxacin—Asthenia—Gemcitabine—pancreatic cancer	0.000277	0.000675	CcSEcCtD
Gatifloxacin—Haematuria—Epirubicin—pancreatic cancer	0.000276	0.000673	CcSEcCtD
Gatifloxacin—Confusional state—Docetaxel—pancreatic cancer	0.000276	0.000673	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000274	0.000669	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000274	0.000668	CcSEcCtD
Gatifloxacin—Oedema—Docetaxel—pancreatic cancer	0.000274	0.000668	CcSEcCtD
Gatifloxacin—Epistaxis—Epirubicin—pancreatic cancer	0.000273	0.000666	CcSEcCtD
Gatifloxacin—Pruritus—Gemcitabine—pancreatic cancer	0.000273	0.000666	CcSEcCtD
Gatifloxacin—Infection—Docetaxel—pancreatic cancer	0.000272	0.000664	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000271	0.000661	CcSEcCtD
Gatifloxacin—Diarrhoea—Irinotecan—pancreatic cancer	0.000271	0.000661	CcSEcCtD
Gatifloxacin—Shock—Docetaxel—pancreatic cancer	0.000269	0.000657	CcSEcCtD
Gatifloxacin—Pruritus—Fluorouracil—pancreatic cancer	0.000268	0.000655	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000268	0.000654	CcSEcCtD
Gatifloxacin—Tachycardia—Docetaxel—pancreatic cancer	0.000267	0.000652	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000265	0.000648	CcSEcCtD
Gatifloxacin—Bradycardia—Epirubicin—pancreatic cancer	0.000264	0.000646	CcSEcCtD
Gatifloxacin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000264	0.000644	CcSEcCtD
Gatifloxacin—Dizziness—Irinotecan—pancreatic cancer	0.000262	0.000639	CcSEcCtD
Gatifloxacin—Stomatitis—Doxorubicin—pancreatic cancer	0.000261	0.000637	CcSEcCtD
Gatifloxacin—Anorexia—Docetaxel—pancreatic cancer	0.000261	0.000637	CcSEcCtD
Gatifloxacin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00026	0.000635	CcSEcCtD
Gatifloxacin—Hepatitis—Epirubicin—pancreatic cancer	0.00026	0.000634	CcSEcCtD
Gatifloxacin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000259	0.000633	CcSEcCtD
Gatifloxacin—Pharyngitis—Epirubicin—pancreatic cancer	0.000258	0.000629	CcSEcCtD
Gatifloxacin—Sweating—Doxorubicin—pancreatic cancer	0.000257	0.000627	CcSEcCtD
Gatifloxacin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000256	0.000625	CcSEcCtD
Gatifloxacin—Hypotension—Docetaxel—pancreatic cancer	0.000256	0.000624	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—pancreatic cancer	0.000255	0.000623	CcSEcCtD
Gatifloxacin—Epistaxis—Doxorubicin—pancreatic cancer	0.000253	0.000616	CcSEcCtD
Gatifloxacin—Vomiting—Irinotecan—pancreatic cancer	0.000252	0.000614	CcSEcCtD
Gatifloxacin—Dizziness—Fluorouracil—pancreatic cancer	0.000251	0.000612	CcSEcCtD
Gatifloxacin—Visual impairment—Epirubicin—pancreatic cancer	0.00025	0.000611	CcSEcCtD
Gatifloxacin—Rash—Irinotecan—pancreatic cancer	0.00025	0.000609	CcSEcCtD
Gatifloxacin—Dermatitis—Irinotecan—pancreatic cancer	0.000249	0.000609	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000249	0.000609	CcSEcCtD
Gatifloxacin—Headache—Irinotecan—pancreatic cancer	0.000248	0.000605	CcSEcCtD
Gatifloxacin—Insomnia—Docetaxel—pancreatic cancer	0.000247	0.000604	CcSEcCtD
Gatifloxacin—Paraesthesia—Docetaxel—pancreatic cancer	0.000246	0.0006	CcSEcCtD
Gatifloxacin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000246	0.0006	CcSEcCtD
Gatifloxacin—Vomiting—Gemcitabine—pancreatic cancer	0.000245	0.000598	CcSEcCtD
Gatifloxacin—Bradycardia—Doxorubicin—pancreatic cancer	0.000245	0.000597	CcSEcCtD
Gatifloxacin—Dyspnoea—Docetaxel—pancreatic cancer	0.000244	0.000595	CcSEcCtD
Gatifloxacin—Somnolence—Docetaxel—pancreatic cancer	0.000243	0.000594	CcSEcCtD
Gatifloxacin—Rash—Gemcitabine—pancreatic cancer	0.000243	0.000593	CcSEcCtD
Gatifloxacin—Dermatitis—Gemcitabine—pancreatic cancer	0.000243	0.000593	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—pancreatic cancer	0.000243	0.000593	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—pancreatic cancer	0.000242	0.000591	CcSEcCtD
Gatifloxacin—Headache—Gemcitabine—pancreatic cancer	0.000242	0.00059	CcSEcCtD
Gatifloxacin—Vomiting—Fluorouracil—pancreatic cancer	0.000241	0.000588	CcSEcCtD
Gatifloxacin—Dyspepsia—Docetaxel—pancreatic cancer	0.000241	0.000588	CcSEcCtD
Gatifloxacin—Hepatitis—Doxorubicin—pancreatic cancer	0.00024	0.000587	CcSEcCtD
Gatifloxacin—Rash—Fluorouracil—pancreatic cancer	0.000239	0.000583	CcSEcCtD
Gatifloxacin—Dermatitis—Fluorouracil—pancreatic cancer	0.000239	0.000583	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000239	0.000582	CcSEcCtD
Gatifloxacin—Decreased appetite—Docetaxel—pancreatic cancer	0.000238	0.000581	CcSEcCtD
Gatifloxacin—Headache—Fluorouracil—pancreatic cancer	0.000237	0.00058	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000237	0.000578	CcSEcCtD
Gatifloxacin—Nausea—Irinotecan—pancreatic cancer	0.000235	0.000574	CcSEcCtD
Gatifloxacin—Constipation—Docetaxel—pancreatic cancer	0.000234	0.000571	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—pancreatic cancer	0.000233	0.000569	CcSEcCtD
Gatifloxacin—Visual impairment—Doxorubicin—pancreatic cancer	0.000232	0.000565	CcSEcCtD
Gatifloxacin—Nausea—Gemcitabine—pancreatic cancer	0.000229	0.000559	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000227	0.000555	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—pancreatic cancer	0.000226	0.000552	CcSEcCtD
Gatifloxacin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000225	0.00055	CcSEcCtD
Gatifloxacin—Nausea—Fluorouracil—pancreatic cancer	0.000225	0.00055	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—pancreatic cancer	0.000225	0.000548	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—pancreatic cancer	0.000224	0.000547	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000224	0.000546	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—pancreatic cancer	0.000223	0.000544	CcSEcCtD
Gatifloxacin—Tension—Epirubicin—pancreatic cancer	0.000222	0.000542	CcSEcCtD
Gatifloxacin—Dysgeusia—Epirubicin—pancreatic cancer	0.000221	0.000541	CcSEcCtD
Gatifloxacin—Nervousness—Epirubicin—pancreatic cancer	0.00022	0.000536	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—pancreatic cancer	0.000219	0.000534	CcSEcCtD
Gatifloxacin—Muscle spasms—Epirubicin—pancreatic cancer	0.000217	0.000531	CcSEcCtD
Gatifloxacin—Abdominal pain—Docetaxel—pancreatic cancer	0.000216	0.000528	CcSEcCtD
Gatifloxacin—Body temperature increased—Docetaxel—pancreatic cancer	0.000216	0.000528	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—pancreatic cancer	0.000216	0.000526	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—pancreatic cancer	0.000213	0.00052	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—pancreatic cancer	0.000209	0.000511	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—pancreatic cancer	0.000208	0.000507	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—pancreatic cancer	0.000206	0.000503	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—pancreatic cancer	0.000205	0.000501	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000205	0.0005	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—pancreatic cancer	0.000203	0.000496	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—pancreatic cancer	0.000203	0.000496	CcSEcCtD
Gatifloxacin—Syncope—Epirubicin—pancreatic cancer	0.000203	0.000495	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—pancreatic cancer	0.000202	0.000494	CcSEcCtD
Gatifloxacin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000202	0.000492	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000201	0.000491	CcSEcCtD
Gatifloxacin—Palpitations—Epirubicin—pancreatic cancer	0.0002	0.000488	CcSEcCtD
Gatifloxacin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000199	0.000485	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—pancreatic cancer	0.000197	0.000481	CcSEcCtD
Gatifloxacin—Asthenia—Docetaxel—pancreatic cancer	0.000196	0.000479	CcSEcCtD
Gatifloxacin—Convulsion—Epirubicin—pancreatic cancer	0.000196	0.000478	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—pancreatic cancer	0.000195	0.000477	CcSEcCtD
Gatifloxacin—Pruritus—Docetaxel—pancreatic cancer	0.000194	0.000473	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—pancreatic cancer	0.000192	0.00047	CcSEcCtD
Gatifloxacin—Chest pain—Epirubicin—pancreatic cancer	0.000192	0.00047	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—pancreatic cancer	0.000192	0.00047	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—pancreatic cancer	0.000192	0.000469	CcSEcCtD
Gatifloxacin—Anxiety—Epirubicin—pancreatic cancer	0.000192	0.000468	CcSEcCtD
Gatifloxacin—Vertigo—Doxorubicin—pancreatic cancer	0.000188	0.000459	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—pancreatic cancer	0.000188	0.000458	CcSEcCtD
Gatifloxacin—Diarrhoea—Docetaxel—pancreatic cancer	0.000187	0.000457	CcSEcCtD
Gatifloxacin—Confusional state—Epirubicin—pancreatic cancer	0.000186	0.000454	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—pancreatic cancer	0.000185	0.000451	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000185	0.000451	CcSEcCtD
Gatifloxacin—Oedema—Epirubicin—pancreatic cancer	0.000185	0.000451	CcSEcCtD
Gatifloxacin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000184	0.000449	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—pancreatic cancer	0.000183	0.000448	CcSEcCtD
Gatifloxacin—Shock—Epirubicin—pancreatic cancer	0.000182	0.000443	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—pancreatic cancer	0.000181	0.000443	CcSEcCtD
Gatifloxacin—Dizziness—Docetaxel—pancreatic cancer	0.000181	0.000442	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000181	0.000441	CcSEcCtD
Gatifloxacin—Hypertension—Doxorubicin—pancreatic cancer	0.000181	0.000441	CcSEcCtD
Gatifloxacin—Tachycardia—Epirubicin—pancreatic cancer	0.00018	0.00044	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000178	0.000436	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—pancreatic cancer	0.000178	0.000435	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—pancreatic cancer	0.000178	0.000435	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—pancreatic cancer	0.000178	0.000435	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—pancreatic cancer	0.000177	0.000433	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—pancreatic cancer	0.000176	0.000429	CcSEcCtD
Gatifloxacin—Vomiting—Docetaxel—pancreatic cancer	0.000174	0.000425	CcSEcCtD
Gatifloxacin—Rash—Docetaxel—pancreatic cancer	0.000173	0.000421	CcSEcCtD
Gatifloxacin—Hypotension—Epirubicin—pancreatic cancer	0.000172	0.000421	CcSEcCtD
Gatifloxacin—Dermatitis—Docetaxel—pancreatic cancer	0.000172	0.000421	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—pancreatic cancer	0.000172	0.00042	CcSEcCtD
Gatifloxacin—Headache—Docetaxel—pancreatic cancer	0.000171	0.000418	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000171	0.000417	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—pancreatic cancer	0.000171	0.000417	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—pancreatic cancer	0.00017	0.000414	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000168	0.00041	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—pancreatic cancer	0.000168	0.00041	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000167	0.000408	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—pancreatic cancer	0.000167	0.000407	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—pancreatic cancer	0.000167	0.000407	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—pancreatic cancer	0.000166	0.000405	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000165	0.000403	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—pancreatic cancer	0.000165	0.000402	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—pancreatic cancer	0.000164	0.000401	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—pancreatic cancer	0.000163	0.000397	CcSEcCtD
Gatifloxacin—Nausea—Docetaxel—pancreatic cancer	0.000163	0.000397	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—pancreatic cancer	0.000162	0.000397	CcSEcCtD
Gatifloxacin—Decreased appetite—Epirubicin—pancreatic cancer	0.00016	0.000392	CcSEcCtD
Gatifloxacin—Hypotension—Doxorubicin—pancreatic cancer	0.00016	0.00039	CcSEcCtD
Gatifloxacin—Constipation—Epirubicin—pancreatic cancer	0.000158	0.000385	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000156	0.00038	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—pancreatic cancer	0.000154	0.000377	CcSEcCtD
Gatifloxacin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000153	0.000374	CcSEcCtD
Gatifloxacin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000152	0.000372	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000152	0.000371	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—pancreatic cancer	0.000152	0.000371	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000151	0.000368	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—pancreatic cancer	0.00015	0.000367	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000148	0.000362	CcSEcCtD
Gatifloxacin—Urticaria—Epirubicin—pancreatic cancer	0.000147	0.000358	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—pancreatic cancer	0.000146	0.000356	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—pancreatic cancer	0.000146	0.000356	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—pancreatic cancer	0.000146	0.000356	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000141	0.000344	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00014	0.000341	CcSEcCtD
Gatifloxacin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000136	0.000332	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—pancreatic cancer	0.000136	0.000331	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000135	0.00033	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000135	0.00033	CcSEcCtD
Gatifloxacin—Asthenia—Epirubicin—pancreatic cancer	0.000132	0.000323	CcSEcCtD
Gatifloxacin—Pruritus—Epirubicin—pancreatic cancer	0.000131	0.000319	CcSEcCtD
Gatifloxacin—Diarrhoea—Epirubicin—pancreatic cancer	0.000126	0.000308	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000126	0.000307	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—pancreatic cancer	0.000123	0.000299	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—pancreatic cancer	0.000122	0.000298	CcSEcCtD
Gatifloxacin—Pruritus—Doxorubicin—pancreatic cancer	0.000121	0.000295	CcSEcCtD
Gatifloxacin—Vomiting—Epirubicin—pancreatic cancer	0.000117	0.000286	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000117	0.000285	CcSEcCtD
Gatifloxacin—Rash—Epirubicin—pancreatic cancer	0.000116	0.000284	CcSEcCtD
Gatifloxacin—Dermatitis—Epirubicin—pancreatic cancer	0.000116	0.000284	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—pancreatic cancer	0.000116	0.000282	CcSEcCtD
Gatifloxacin—Dizziness—Doxorubicin—pancreatic cancer	0.000113	0.000276	CcSEcCtD
Gatifloxacin—Nausea—Epirubicin—pancreatic cancer	0.00011	0.000268	CcSEcCtD
Gatifloxacin—Vomiting—Doxorubicin—pancreatic cancer	0.000109	0.000265	CcSEcCtD
Gatifloxacin—Rash—Doxorubicin—pancreatic cancer	0.000108	0.000263	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—pancreatic cancer	0.000108	0.000263	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—pancreatic cancer	0.000107	0.000261	CcSEcCtD
Gatifloxacin—Nausea—Doxorubicin—pancreatic cancer	0.000101	0.000248	CcSEcCtD
